Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 25 Aug 2021 07:00 CEST |
ARGENX SE | argenx Announces Validation of European Marketing Authorization Application for Efgartigimod in Generalized Myasthenia Gravis | 20103010 Biotechnology | Other subject |
| 04 Aug 2021 07:00 CEST |
ARGENX SE | argenx to Present at 2021 Wedbush PacGrow Virtual Healthcare Conference | 20103010 Biotechnology | Other subject |
| 29 Jul 2021 07:00 CEST |
ARGENX SE | argenx Reports Half Year 2021 Financial Results and Provides Second Quarter Business Update | 20103010 Biotechnology | Other subject |
| 22 Jul 2021 07:00 CEST |
ARGENX SE | argenx to Report Half Year 2021 Financial Results and Second Quarter Business Update on July 29, 2021 | 20103010 Biotechnology | Other subject |
| 14 Jul 2021 07:00 CEST |
ARGENX SE | argenx to Host Virtual R&D Day on July 20, 2021 | 20103010 Biotechnology | Other subject |